Atlanta Allergy & Asthma will be CLOSED on the following days during the 2022 Holiday Season:
Thanksgiving Day (11/24), Day After Thanksgiving (11/25), Monday after Christmas (12/26), and Monday After New Year’s (1/2).

ACAAI 2022 Meeting Reveals Most up to Date Research on Allergies and Asthma

Updated on Thursday, November 17, 2022

Atlanta Allergy & Asthma News

Atlanta Allergy & Asthma physicians recently attended the American College of Allergy, Asthma, and Immunology (ACAAI) Annual Scientific meeting in Louisville. The most up-to-date research was unveiled on allergic diseases and asthma.

Below is a summary of studies that garnered attention:

Sensitive to Pollen? New Study Finds Best Time to Be Outdoors

If you are allergic to pollen, this new study found that there are certain hours of the day that are better than others if you are trying to dodge pollen! Learn more:

https://annualmeeting.acaai.org/2022/lowest-pollen-counts.cfm

Sex Can Trigger an Asthma Attack

In some people, exercise can induce an asthma flare. This study found that sexual activity can be an undiagnosed trigger for asthma exacerbations. Learn more:

https://annualmeeting.acaai.org/2022/asthma-trigger.cfm

Your Smartphone Is a Haven for Allergens

A new study showed smartphones are reservoirs of allergens. With the majority of households owning a smartphone, learn more about which allergens were present and what to do about it.

https://annualmeeting.acaai.org/2022/smartphones.cfm

Dangerous Myths Keep Many Adults with Food Allergies from Getting an Epinephrine Auto Injector

This study found that only half of food allergic adult patients have immediate access to epinephrine, the only medication that can stop anaphylaxis. And 36% of adults believe epi auto injectors can cause negative or life-threatening effects. Learn more:

https://annualmeeting.acaai.org/2022/severe-food-allergy.cfm

Some Schools Cite Liability Fears as Reason for Failure to Stock Asthma Inhalers

State legislatures have implemented stock inhaler programs to ensure schools have an asthma reliever, like albuterol, which can be used by any child in respiratory distress. This study showed that even in states with strong stock albuterol laws, school administrators and prescribing clinicians fear liability in prescribing and administering stock inhalers. Read more:

https://annualmeeting.acaai.org/2022/albuterol.cfm

Positive Outcomes for Infants Who Appropriately Receive Epinephrine for Anaphylaxis

86.4% of infants with anaphylaxis appropriately received epinephrine. The study showed that in infants aged 0-24 months who presented to the emergency department for anaphylaxis, few required hospitalization and most were able to go home after a few hours of observation. Learn more:

https://annualmeeting.acaai.org/2022/epinephrine.cfm